Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Allergic Conjunctivitis
Interventions
DRUG

AC-150 Combo

1 drop in each eye for up to 14 days

DRUG

AC-150A 0.1%

1 drop in each eye once per day for up to 14 days

DRUG

AC-150B 0.005%

1 drop in each eye once per day for up to 14 days

DRUG

Vehicle

1 drop in each eye once per day for up to 14 days

Trial Locations (1)

01810

Ora, Inc, Andover

Sponsors
All Listed Sponsors
lead

Aciex Therapeutics, Inc.

INDUSTRY

NCT01134328 - Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model | Biotech Hunter | Biotech Hunter